Pharmaceutical Manufacturing - Scaling Small Molecule Manufacturing from Lab to Market
View as a Web Page
News Medical
 
  Pharmaceutical Manufacturing Pharmaceutical Manufacturing logo  
  The latest pharmaceutical manufacturing news from News Medical  
 

Direct and Automated Surfactant Quantitation in Biologics FormulationsDirect and Automated Surfactant Quantitation in Biologics Formulations

Discover how benchtop NMR technology enables robust and simplified surfactant analysis in formulations, streamlining analytical workflows for these essential yet complex excipients. By eliminating sample preparation and systematic multi-point calibration, and offering fully automated procedures, it delivers significantly accelerated turnaround time and shortened time-to-result to development and quality control laboratories.

Download the Full Paper
 
 
    Scaling Small Molecule Manufacturing from Lab to MarketScaling Small Molecule Manufacturing from Lab to Market
 
Join leading experts from Pharmaron and industry consultant James Bruno to explore the critical considerations for scaling small molecule drug substance manufacturing from Phase II to commercial production. Learn how to balance process velocity, safety, and security of supply to meet growing market demands efficiently.
 
Discover Key Insights on CMC Scale-Up
 
 
   Blood group A linked to a higher risk of primary biliary cholangitisBlood group A linked to a higher risk of primary biliary cholangitis
 
Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in autoimmune liver disease diagnosis.
 
   Transcription Factor SmMYB53 Drives Enhanced Tanshinone Synthesis in Salvia MiltiorrhizaTranscription Factor SmMYB53 Drives Enhanced Tanshinone Synthesis in Salvia Miltiorrhiza
 
Salvia miltiorrhiza has long been used in traditional medicine, with tanshinones being its main active compounds.
 
   Positioning Barbados as the Caribbean’s Life Sciences HubPositioning Barbados as the Caribbean’s Life Sciences Hub
 
Export Barbados (BIDC) and EarlyHealth Group (EHG), have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world-class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025